5.1% Stake of MISONIX, Inc. (MSON) Owned by South Africa Alpha Capital Management Ltd.
South Africa Alpha Capital Management Ltd.
stated that they own 5.1% of MISONIX, Inc. (NASDAQ:MSON) in a Schedule 13G disclosure that was filed with the Securities and Exchange Commission (SEC) on Friday, November 24th. The investor owns 479,006 shares of the stock worth approximately $5,063,093. The reporting parties listed on the disclosure included South Africa Alpha Capital Management Ltd and Praesidium Capital Management (Pty) Ltd. The filing is available through the SEC website at this link.
Other hedge funds and other institutional investors also recently bought and sold shares of the company. MML Investors Services LLC raised its position in MISONIX by 0.7% in the 2nd quarter. MML Investors Services LLC now owns 14,100 shares of the medical equipment provider’s stock worth $135,000 after purchasing an additional 100 shares during the period. Northern Trust Corp raised its position in MISONIX by 2.5% in the 2nd quarter. Northern Trust Corp now owns 24,378 shares of the medical equipment provider’s stock worth $233,000 after purchasing an additional 591 shares during the period. Finally, Vanguard Group Inc. raised its position in MISONIX by 0.9% in the 2nd quarter. Vanguard Group Inc. now owns 106,353 shares of the medical equipment provider’s stock worth $1,027,000 after purchasing an additional 900 shares during the period. 10.15% of the stock is owned by institutional investors.
Shares of MISONIX, Inc. (MSON) traded up $0.02 during trading hours on Friday, reaching $10.57. 3,200 shares of the company were exchanged, compared to its average volume of 8,092. MISONIX, Inc. has a one year low of $7.05 and a one year high of $12.00.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for MISONIX Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MISONIX Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.